Literature DB >> 16430921

Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B.

Stefan Sikorra1, Tina Henke, Subramanyam Swaminathan, Thierry Galli, Thomas Binz.   

Abstract

Botulinum neurotoxins types B, D, F, and G, and tetanus neurotoxin inhibit vesicular fusion via proteolytic cleavage of VAMP/Synaptobrevin, a core component of the membrane fusion machinery. Thus, these neurotoxins became widely used tools for investigating vesicular trafficking routes. Except for VAMP-1, VAMP-2, and Cellubrevin, no other member of the VAMP family represents a substrate for these neurotoxins. The molecular basis for this discrepancy is not known. A 34 amino acid residue segment of VAMP-2 was previously suggested to mediate the interaction with botulinum neurotoxin B, but the validity of the data was later questioned. To check whether this segment alone controls the susceptibility toward botulinum neurotoxin B, it was used to replace the corresponding segment in TI-VAMP. The resulting VAMP hybrid and VAMP-2 were hydrolysed at virtually identical rates. Resetting the VAMP-2 portion in the hybrid from either end to TI-VAMP residues gradually reduced the cleavability. A hybrid encompassing merely the VAMP-2 segment 71-80 around the Gln76/Phe77 scissile bond was still hydrolysed, albeit at a approximately tenfold lower cleavage rate. The contribution of each non-conserved amino acid of the whole 34-mer segment to the interaction was investigated employing VAMP-2. We find that the eight non-conserved residues of the 71-80 segment are all necessary for efficient cleavage. Mutation of an additional six residues located upstream and downstream of this segment affects substrate hydrolysis as well. Vice versa, a readily cleavable TI-VAMP molecule requires at the least the replacement of Ile158, Thr161, and the section 165-174 by Asp64, Ala67, and the 71-80 segment of VAMP-2, respectively. However, the insensitivity of TI-VAMP to botulinum neurotoxin B relies on at least 12 amino acid changes versus VAMP-2. These are scattered along an interface of 22 amino acid residues in length.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430921     DOI: 10.1016/j.jmb.2005.12.075

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

Review 1.  Botulinum neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

Review 2.  Toxins from bacteria.

Authors:  James S Henkel; Michael R Baldwin; Joseph T Barbieri
Journal:  EXS       Date:  2010

3.  Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.

Authors:  Kwok-Ho Lam; Stefan Sikorra; Jasmin Weisemann; Hannah Maatsch; Kay Perry; Andreas Rummel; Thomas Binz; Rongsheng Jin
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

4.  Coupled activity-dependent trafficking of synaptic SK2 channels and AMPA receptors.

Authors:  Mike T Lin; Rafael Luján; Masahiko Watanabe; Matthew Frerking; James Maylie; John P Adelman
Journal:  J Neurosci       Date:  2010-09-01       Impact factor: 6.167

5.  Basic tetrapeptides as potent intracellular inhibitors of type A botulinum neurotoxin protease activity.

Authors:  Martha Hale; George Oyler; Subramanyam Swaminathan; S Ashraf Ahmed
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

6.  Insights into the different catalytic activities of Clostridium neurotoxins.

Authors:  Sheng Chen; Andrew P A Karalewitz; Joseph T Barbieri
Journal:  Biochemistry       Date:  2012-04-24       Impact factor: 3.162

7.  Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.

Authors:  Sheng Chen; Cherisse Hall; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2008-05-29       Impact factor: 5.157

8.  Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.

Authors:  Stefan Sikorra; Tina Henke; Thierry Galli; Thomas Binz
Journal:  J Biol Chem       Date:  2008-05-29       Impact factor: 5.157

9.  Catalytic properties of botulinum neurotoxin subtypes A3 and A4.

Authors:  James S Henkel; Mark Jacobson; William Tepp; Christina Pier; Eric A Johnson; Joseph T Barbieri
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

Review 10.  Receptor and substrate interactions of clostridial neurotoxins.

Authors:  Axel T Brunger; Andreas Rummel
Journal:  Toxicon       Date:  2009-03-04       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.